Institut des Maladies Métaboliques et Cardiovasculaires

OrganisationROR

People

Sources: openalex.org

Grants and prizes

  • Agence Nationale de la Recherche

    EP PerMed, Calprotectin as a new companion biomarker and associated drug target for premature vascular aging in chronic kidney disease and type 2 diabetes, ANR-24-EPPM-0001, €329.9k, 2025, 1 Apr 2025

  • Agence Nationale de la Recherche

    AAPG2023, Timing of eating and exercise as a novel strategy to preserve muscle mass and improve glycemic control in obese post-menopausal women with type 2 diabetes, ANR-23-CE17-0059, €477.9k, 2024, 1 Apr 2024

  • Agence Nationale de la Recherche

    AAPG2023, Deciphering the role of two novel exerkines in the prevention of metabolic disorders related to lifestyle and aging, ANR-23-CE14-0021, €355.8k, 2024, 1 Mar 2024

  • Agence Nationale de la Recherche

    AAPG2023, Targeting immunosenescence in acute kidney injury, ANR-23-CE14-0069, €344k, 2024, 1 Feb 2024

  • Agence Nationale de la Recherche

    AAPG2023, Circadian regulation of estrogen signaling: Toward Chronotherapeutic strategy in menopausal women, ANR-23-CE14-0002, €377.2k, 2023, 1 Oct 2023

  • Agence Nationale de la Recherche

    AAPG2023, Alteration of endothelial estrogen receptor (ER)alpha with ageing : consequences for women arterial protection, ANR-23-CE14-0005, €539k, 2023, 1 Oct 2023

  • Agence Nationale de la Recherche

    AAPG2019, Role of cAMP signalosomes in cardiomyocyte senescence and age-associated heart failure, ANR-19-CE14-0038, €490.3k, 2020, 1 Jan 2020

  • Agence Nationale de la Recherche

    AAPG2019, Role of haptoglobin in the adipocyte-muscle crosstalk during age-associated sarcopenia, ANR-19-CE14-0007, €322.8k, 2019, 1 Oct 2019

Sources: openalex.org